盐霉素纳米制剂的研究进展

Advances in the nanotechnology-based drug delivery systems of salinomycin

盐霉素(salinomycin,SAL)作为一种抗生素,已广泛用于畜牧业,近年来研究人员发现该药对多种肿瘤及肿瘤干细胞具有较强的抑制作用,而且体内外研究及早期临床试验结果均表明SAL具有抗肿瘤多重耐药活性,有望成为一种新型的抗肿瘤药物。但是,SAL的水溶性较差,且有一定的毒副作用,为获得更好的治疗效果,SAL制剂学的研究得到药学界的广泛关注。本文对近年来SAL纳米制剂的研究进展进行综述。

Salinomycin ,extensively used as an antibiotic in animal husbandry for a long time ,has recently been found to possess strong anti-cancer and anti-cancer stem cell efficacy ,as well as activities to overcome multi-drug resistance of tumor based on studies in vivo and in vitro in case reports in pilot clinical trials .Therefore ,salinomycin promised to be a novel anti-cancer agent .However ,the unfavorable property of poor aqueous solubility and the adverse effects of salinomycin were greatly hinder its clinical use .In order to improve its therapeutic index and alleviate its toxicity ,studies on nanotechnology-based deliv-ery systems of salinomycin had been widely conducted .In this article ,the latest development and application of salinomycin nanoformulations were reviewed .